1970
DOI: 10.3329/jdmc.v18i2.6269
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of Hepatitis C Virus in Thalassemic Patients

Abstract: Hepatitis C virus is one of the leading causes of liver disease and represents a major public health problem. It is a common cause of cirrhosis and hepatocellular carcinoma (HCC) as well as the most common reason for liver transplantation. This cross sectional study was carried out during the period of April 2007 to April 2008 among thalassemic patients with history of multiple blood transfusion (>20 units). Total 200 thalassemic patients from Thalassemia Samity Hospital, Green Road, Bangladesh Thalassemia … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…In this study, we found that older age of the patients, longer duration of the disease in years, elevated liver enzymes (U/L), and increasing ferritin level (ng/mL) are associated with higher seroprevalence of TTIs. Similar findings were reported by other studies [ 37 – 39 ]. Though the standardized blood screening procedures were outlined in the 1990s for blood-related products and were subsequently implemented in various countries, higher prevalence of TTIs, especially HCV, among thalassemic patients requires greater attention from a public health perspective.…”
Section: Discussionsupporting
confidence: 93%
“…In this study, we found that older age of the patients, longer duration of the disease in years, elevated liver enzymes (U/L), and increasing ferritin level (ng/mL) are associated with higher seroprevalence of TTIs. Similar findings were reported by other studies [ 37 – 39 ]. Though the standardized blood screening procedures were outlined in the 1990s for blood-related products and were subsequently implemented in various countries, higher prevalence of TTIs, especially HCV, among thalassemic patients requires greater attention from a public health perspective.…”
Section: Discussionsupporting
confidence: 93%
“…Both the HBV and HCV cause liver damage. They lead to chronic liver disease, cirrhosis, hepatocellular carcinoma (HCC), end stage liver disease and death and are the most common transfusion transmitted infections (5,(10)(11).…”
Section: Introductionmentioning
confidence: 99%